Cargando…
Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future
Metabolomics and lipidomics are emerging methods for detailed phenotyping of small molecules in samples. It is hoped that such data will: (i) enhance baseline prediction of patient response to pharmacotherapies (beneficial or adverse); (ii) reveal changes in metabolites shortly after initiation of t...
Autores principales: | Rankin, Naomi J, Preiss, David, Welsh, Paul, Sattar, Naveed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100629/ https://www.ncbi.nlm.nih.gov/pubmed/27789671 http://dx.doi.org/10.1093/ije/dyw271 |
Ejemplares similares
-
The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective
por: Rankin, Naomi J., et al.
Publicado: (2014) -
NMR and Metabolomics—A Roadmap for the Future
por: Wishart, David S., et al.
Publicado: (2022) -
Obesity in Children and Future Cardiometabolic Risk: Are blood tests necessary?
por: Logue, Jennifer, et al.
Publicado: (2010) -
Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity
por: Bowman, P., et al.
Publicado: (2018) -
Advances in the clinical management of type 2 diabetes: a brief history of the past 15 years and challenges for the future
por: Sattar, Naveed
Publicado: (2019)